Sanoflore Laboratories

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Sanoflore Laboratories - overview

Established

1986

Location

-, -, France

Primary Industry

Consumer Products

About

Based in France and founded in 1986 by Rodolphe Balz, Sanoflore Laboratories, operates as an organic beauty brand developing natural skincare products with ingredients like citric acid, hyaluronic acid, lactic acid, phytic acid, and many more. In October 2023, Ekkio Capital acquired a majority stake in Sanoflore laboratories from L'Oreal. As of 2023, the company is led by its CEO, Sergio Calandri. The company offers various skin care products that include face and eye make-up remover milk, tinted healthy glow moisturizing face cream, absolute wonderful eye serum, organic anti-blemish cleansing jelly, anti-wrinkle face night dry oil, rose hydrosol radiance mist, organic cornflower hydrosol, and many more.


The company offers skincare products for treatment of anti-wrinkle, anti-aging care, moisturizing care, dark circles, bags and wrinkles, and detoxifying treatments.


Current Investors

Ekkio Capital

Primary Industry

Consumer Products

Sub Industries

Beauty & Hygiene

Website

www.sanoflore.fr

Verticals

Manufacturing

Total Amount Raised

Subscriber access only

Sanoflore Laboratories - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Corporate Carve OutCompletedSanoflore Laboratories-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.